Stockscreener 앱 받기
195.12
1.74%
3.3397
시간 외 거래:
195.18
0.0603
+0.03%
전일 마감가:
$191.78
열려 있는:
$191.88
하루 거래량:
7,669
Relative Volume:
0.88
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.12%
1개월 성능:
+1.68%
6개월 성능:
+18.40%
1년 성능:
+20.63%
1일 변동 폭
$191.88
$196.79
1주일 범위
$190.79
$199.44
52주 변동 폭
$135.34
$202.91
Vaneck Biotech Etf Stock (BBH) Company Profile
Compare BBH vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
195.12 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.65 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.75 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.76 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
276.30 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
601.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf 주식(BBH)의 최신 뉴스
7 Best Biotech ETFs to Buy Now - US News Money
How AI Is Reshaping Drug Discovery And Healthcare Investing - Seeking Alpha
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Moderna’s rally ripples through biotech and health care ETFs - MSN
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
December Market Recap: Innovation Matures, Constraints Tighten, Money Evolves - VanEck
Precious Metals Define Commodity Performance in 2025 - VanEck
IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns - Seeking Alpha
Why VanEck Morningstar International Moat ETF stock is upgraded to buyJuly 2025 Macro Moves & Free Community Consensus Stock Picks - ulpravda.ru
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
VanEck ETF TrustVanEck Biotech ETF announces Annual dividend, payable on December 26, 2025 - marketscreener.com
The Next Phase of Retail: How Consumer Behavior and Technology Are Shaping the Industry - VanEck
Defense Start-ups Galvanize a Once Sleepy Sector - VanEck
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
What If AI Went Away Today? A Simple Look at Semiconductors - VanEck
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
EDGAR Filing Documents for 0000930413-25-003577 - SEC.gov
How Much More Tightening in EM? - VanEck
Inflation Persistence in EM - VanEck
Yield Advantage: Why EM Local Bonds Are Leading DM Bonds in 2025 - VanEck
Chinese Bonds Offer Yield Pickup - VanEck
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025 - Blockchain News
EM High Yield Corporates: Superior Yields, Low Defaults - VanEck
How India’s Digital Economy Compares to China - VanEck
InflationDownside Surprises Stage Comeback - VanEck
Higher for LongerMarket Not So Sure - VanEck
Global Pressures – Pick a Direction - VanEck
AI in Pharma and Biotech: Market Trends 2025 and Beyond - VanEck
AI In Pharma And Biotech: Market Trends 2025 And Beyond - Seeking Alpha
China – Lockdowns, Growth, Policy Options - VanEck
Sentiment Swings and Fundamentals - VanEck
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - The AI Journal
Tema Oncology ETF (CANC) Passes $100m AUM, Among Top 3 2025 Healthcare ETFs - Stock Titan
The Global Power Crunch: The New Geopolitical and Economic Frontier - VanEck
Rates and Consequences - VanEck
Gold Responds and Reminds in March - VanEck
Vaneck Biotech Etf (BBH) 재무 분석
Vaneck Biotech Etf (BBH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.74%
0.47%
자본화:
|
볼륨(24시간):